|
|
| (28 intermediate revisions by 3 users not shown) |
| Line 1: |
Line 1: |
| − | The [[Medical Technology Group]] (MTG) is a trade organization, working for different companies, patient groups, charities and other trade associations in the pharmaceutical industry. The MTG was launched in 2000 to make medical technologies available to everyone who needs them. The MTG works towards achieving a cutting edge NHS where patients are guaranteed access to effective medical technologies. <ref> ABHI [http://www.abhi.org.uk/key-issues/public-affairs/medical-technology-group.aspx Medical Technology Group], accessed Feb 2011</ref> The MTG does not have any competitors, like they write on their homepage, they are “the only UK coalition of industry groups and patient charities working together to improve patient access to effective medical technologies”. <ref> MTG [http://www.mtg.org.uk/ Competitors], accessed 11.02.2011</ref> | + | The '''Medical Technology Group''' (MTG) describes itself as "a coalition of patient groups, research charities and medical device manufacturers working to make medical technologies available to everyone who needs them."<ref> MTG website [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=2 About MTG], accessed Nov 2010</ref> The Group was launched in 2000 to lobby for medical technologies in the NHS. |
| | | | |
| | + | ==Background== |
| | | | |
| − | AdvaMed, a members of the MTG, writes on their homepage that, “the Medical Technology Group represents drug and device manufacturers and trade associations on all aspects of federal and state regulation of medical technology, including the requirements of the Food and Drug Administration, Health Care Financing Administration, Centers for Disease Control and Prevention, the Federal Trade Commission, and State Medicaid Agencies”. <ref> AdvaMed [http://www.advamed.org/MemberPortal/Membership/associate/associate_member_roster.htm Associate Members], accessed 02.03.2011</ref>
| + | The global medical technology market is worth an estimated £150-170bn and the proportion of healthcare expenditure spent on medical technology is increasing. |
| | | | |
| − | ==Economy==
| + | The USA is the largest market worth over £70bn and has a strong supply base with most of world’s largest medical technology companies originating there. <ref> Department for Business, Innovation & Skills [http://www.bis.gov.uk/assets/biscore/business-sectors/docs/s/10-p90-strength-and-opportunity-bioscience-and-health-technology-sectors.pdf Strength andOpportunity] Dec 2010, accessed 28.03.2011 </ref> |
| − | Many, including The MTG, believe that that the uptake of medical technologies is not as good as it should be in the UK. The UK medical technology sector in 2010 consists of 3034 companies generating a turnover of £13.1bn and employing 55 000 individuals. Barbara Harpham, Medical Technology Group chairman and director of Heart Research UK claims that, UK lag behind many other European countries, with problems like hospitals denying patients NICE-approved technologies because they lack the facilities or staff to support their use. <ref> Nursing Times [http://www.nursingtimes.net/whats-new-in-nursing/news-topics/health-informatics/nhs-must-boost-use-of-technology-or-risk-falling-behind/5008942.article NHS 'must boost use of technology' or risk falling behind] 25.11.2009, accessed 09.04.2011 </ref> Norman Lamb MP, the Liberal Democrat Shadow Health Secretary, agree that it should be more focus on medical technology. He says that, “adoption of medical technologies is often both cost effective and in the patient’s interest. Up until now, the NHS has been slow to recognise the value of technology. This has to change if we are to maximise the effective use of resources for the benefit of patients”. <ref> Scottish Healthcare [http://www.scottishhealthcare.com/2009/11/page/2/ Medical Technology Group Warns Against ‘Slow-Tech’ NHS] 25.11.2009, accessed 04.042011</ref>
| |
| | | | |
| | + | The UK medical technology sector in 2010 consisted of 3034 companies generating a turnover of £13.1bn and employing 55,000 individuals. [[Barbara Harpham]], Medical Technology Group chairman and director of [[Heart Research UK]] claimed the UK lags behind many other European countries, with problems like hospitals denying patients NICE-approved technologies because they lack the facilities or staff to support their use.<ref> "Nursing Times'' [http://www.nursingtimes.net/whats-new-in-nursing/news-topics/health-informatics/nhs-must-boost-use-of-technology-or-risk-falling-behind/5008942.article NHS "must boost use of technology" or risk falling behind] 25.11.2009, accessed 09.04.2011 </ref> |
| | | | |
| − | “The global medical technology market is estimated to be worth £150-170bn and the proportion of healthcare expenditure spent on medical technology is increasing. The USA is the largest market worth over £70bn and has a strong supply base with the majority of world’s largest medical technology companies originating in the country”. <ref> Department for Business, Innovation & Skills [http://www.bis.gov.uk/assets/biscore/business-sectors/docs/s/10-p90-strength-and-opportunity-bioscience-and-health-technology-sectors.pdf Strength and
| + | The UK spends just 4.5 per cent of its healthcare budget on technology, compared with a European average of 6.3%. MTG claims that this "leads to British patients missing out, for example life saving pacemakers are implanted in Germany at twice the UK rate”. <ref> MTG [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=11 MTG Policy Statements], accessed 11.02.2011</ref> |
| − | Opportunity] Dec 2010, accessed 28.03.2011</ref> “The UK spends just 4.5% of its healthcare budget on technology, compared with a European average of 6.3%. This leads to British patients missing out, for example life saving pacemakers are implanted in Germany at twice the UK rate”. <ref> MTG [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=11 MTG Policy Statements], accessed 11.02.2011</ref>
| |
| | | | |
| − | ==Medical Technology== | + | ==MTG members== |
| − | AdvaMed claims that medical technology is used to diagnose, monitor or treat every disease or condition that affects humans. They write that these innovative technologies are improving the quality of health care delivered and patient outcomes through earlier diagnosis, less invasive treatment options and reductions in hospital stays and rehabilitation times. <ref> AdvaMed [http://www.advamed.org/MemberPortal/About/NewsRoom/MediaKits/whatismedtechnology.htm What is Medical Technology?], 14.09.2004, accessed 06.04.2011 </ref> Barbara Harpham says that, “slashing budgets is counterproductive as modern technologies help thousands of people stay in work and out of hospital” <ref> Scottish Healthcare [http://www.scottishhealthcare.com/2009/11/page/2/ NHS 'must boost use of technology], 25.11.2009, accessed 09.04.2011 </ref> The global medical publisher, BMJ Group writes that, “medical technologies can improve clinical outcomes and experiences of patients and support the wellbeing and personal development of individuals. They can help to achieve savings for the NHS and other areas of public spending in a tight budgetary climate, by improving rehabilitation and independence, supporting care closer to home, and reducing planned and emergency hospital admissions”. <ref> BMJ Group [http://www.bmj.com/content/342/bmj.d566.short/reply UK must increase uptake of medical technology to close gap with Europe] 03.02.2011, accessed 03.04.2011 </ref>
| + | MTG consists of 40 members, and works as a partnership. It includes individual medical technology companies as well as trade associations. |
| − | | |
| − | | |
| − | The Medical Technology Group have worked to improve patient access to effective medical technologies, such as Computer Navigated Orthopaedic Surgery, Spinal Cord Stimulator, heart blankets <ref> MTG [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=16 Key Facts] accessed 20.03.2011 </ref> and insulin pumps. <ref> Weber Shandwick [http://www.scribd.com/doc/42069182/Weber-Shandwick-Presentation-FINAL Medical Technology Group, 2009 End of year review and forward look] accessed 02.04.2011 </ref> None of the products they have promoted have failed. The products they introduce for patients in the UK have been carefully tested, before the Medical Technology Group distributes information about them. As a result, none of their products can be said to have failed.
| |
| − | | |
| − | | |
| − | Heart blankets is an example of a product the Medical Technology Group have promoted on their websites and in other medias. Scientists at Leeds University are at a crucial stage in the development of an innovative artificial heart muscle that helps the heart to beat, called heart blankets. “The technology, made of a web of special material positioned around the heart, has sensors that recognise when the heart wants to beat, triggering a series of miniature motors to make the web contract, helping the heart push blood around the body”. <ref> Docstoc [http://www.docstoc.com/docs/69257722/Key-Facts-about-Heart-Blankets-Pioneering-treatment-for-heart Key Facts about Heart Blankets Pioneering treatment for heart] 2008, accessed 14.04.2011 </ref>. Barbara Harpham claims that this is an amazing new technology that could benefit thousands and save a massive amount of money for the NHS. She says that it’s great that it is being developed in the UK and funded by a UK charity, and that this is a product that can benefit many patients and their families. <ref> MTG [http://www.mtg.org.uk/download/file/pdf/Issues-and-outcomes-key-facts-about-medical-technology_Heart-Blanket.doc.pdf Key Facts about Heart Blankets] 2008, accessed 20.03.2011 </ref>
| |
| − | | |
| − | ==What the MTG wants==
| |
| − | The MTG mean that medical technology gives value for money to the NHS, patients and taxpayers. The MTG also believe that uptake of medical technology in the UK is not as good as it should be, and that people need more information about medical technologies to help unlock their value. The MTG therefore wants patients to get more information about what technologies are available and appropriate for them, to enable shared decision‐making. The second thing they want is training and guidance for clinicians on the choices of medical technology available and how to use them. The MTG also wants dissemination of guidance and best practice that explains the patient and cost benefits of appropriate use of medical technology to those commissioning services. The last two things the MTG want is involvement of patients in commissioning decisions, and a top‐down systems that incentivise quality and cost effectiveness rather than short-term cost reduction. <ref> MTG and NHS [http://nhsalliance2010.org.uk/MTG%20fringe%20meeting.pdf Achieving QIPP through improved use of technology in the NHS], accessed 20.02.2011 </ref>
| |
| − | | |
| − | | |
| − | ==The MTG members==
| |
| − | The Medical Technology Group consists of 40 members, and it works as a partnership. “Partnerships are defined as purposive strategic relationships between independent firms who share compatible goals, strive for mutual benefit, and acknowledge a high level of mutual interdependence. They join efforts to achieve goals that each firm, acting alone, could not attain easily”. <ref> Mohr, Jakki and Robert Speakman [http://onlinelibrary.wiley.com/doi/10.1002/smj.4250150205/pdf Characteristics of Partnership Success: Partnership Attributes, Communication Behavior, and Conflict Resolution Techniques] 1994, accessed 04.03.2011 </ref>
| |
| − | | |
| − | | |
| − | ===List of members:===
| |
| | | | |
| | [[AdvaMed]], [[Abbot Medical Optics]], [[AntiCoagulation Europe]], [[ARMA]], [[Arrhythmia Alliance]], [[Arthritis Care]], [[Atrial Fibrillation Association]], [[Association of British Healthcare Industries]], [[BD]], [[Bladder and Bowel Foundation]], [[Boston Scientific]], [[British Cardiac Patients’ Association]], [[Cardiomyopathy Association]], [[Circulation Foundation]], [[ConvaTec]], [[CR Bard]], [[Dexcom]], [[Eucomed]], [[FABLE]], [[FEmISA]], [[Heart Research UK]], [[ICD Group]], [[Inappropriate Sinus Tachycardia Info and Support]], [[International Alliance of Patients’ Organizations]], [[INPUT]], [[Johnson & Johnson]], The [[Juvenile Diabetes Research Foundation]], The [[Lindsay Leg Club Foundation]], [[Medtronic]], [[National Rheumatoid Arthritis Society]], [[The Patients Association]], [[Patient Information Forum]], [[Pelvic Pain Support Network]], [[Roche Diagnostics]], [[SADS UK]], [[St Jude Medical]], [[STARS]], [[Stryker]], [[Transplant Support Network]], [[Zimmer]].<ref>MTG [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=4 Members], accessed 11.02.2011</ref> | | [[AdvaMed]], [[Abbot Medical Optics]], [[AntiCoagulation Europe]], [[ARMA]], [[Arrhythmia Alliance]], [[Arthritis Care]], [[Atrial Fibrillation Association]], [[Association of British Healthcare Industries]], [[BD]], [[Bladder and Bowel Foundation]], [[Boston Scientific]], [[British Cardiac Patients’ Association]], [[Cardiomyopathy Association]], [[Circulation Foundation]], [[ConvaTec]], [[CR Bard]], [[Dexcom]], [[Eucomed]], [[FABLE]], [[FEmISA]], [[Heart Research UK]], [[ICD Group]], [[Inappropriate Sinus Tachycardia Info and Support]], [[International Alliance of Patients’ Organizations]], [[INPUT]], [[Johnson & Johnson]], The [[Juvenile Diabetes Research Foundation]], The [[Lindsay Leg Club Foundation]], [[Medtronic]], [[National Rheumatoid Arthritis Society]], [[The Patients Association]], [[Patient Information Forum]], [[Pelvic Pain Support Network]], [[Roche Diagnostics]], [[SADS UK]], [[St Jude Medical]], [[STARS]], [[Stryker]], [[Transplant Support Network]], [[Zimmer]].<ref>MTG [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=4 Members], accessed 11.02.2011</ref> |
| | | | |
| | + | ==Lobbying for its members== |
| | | | |
| − | The MTG includes individual medical technology companies as well as trade associations. Here are three, a bit deeper, examples of members of the MTG: [[Association of British Healthcare Industries]], [[AdvaMed]], [[Eucomed]] as well as individual medical technology companies.
| + | ===Weber Shandwick=== |
| − | | |
| − | | |
| − | ===The Association of British Healthcare Industries=== | |
| − | The Association of British Healthcare Industries (ABHI) is the industry association for the medical technology sector in the UK. They represent companies whose output makes up for around eighty five percent of the industry’s total. ABHI was formed 20 years ago to address Industry’s need to engage with the fast moving regulatory landscape and to support UK companies export their products around the world. ABHI has teams focusing on: UK market affairs; research & innovation; international policy; communications and public affairs; technical and regulatory issues; environmental issues; and events and exhibitions. They state that their membership includes some of the leading multinational businesses in the sector in the UK right the way through to small and medium sized enterprises. ABHI aim is to promote the rapid adoption of medical technologies to ensure optimum patient outcomes throughout the UK and in key global markets. ABHI membership is open to manufacturers as well as service companies involved in the health sector, such as distributors, professional groups and lawyers. <ref> ABHI [http://www.abhi.org.uk/about/about-abhi.aspx About ABHI] accessed 16.04.2011 </ref>
| |
| | | | |
| | + | PR and lobbying company, [[Weber Shandwick]] provides the Secretariat to MTG and acts as its contact point. <ref> MTG and INPUT [http://www.technologyadoptioncentre.nhs.uk/assets/_files/documents/jun_10/nhs__1276784218_Medical_Technology_Group_Infor.pdf AUDIT OF INSULIN PUMP THERAPY PROVISION AT PRIMARY CARE TRUST (PCT) LEVEL TO BE PUBLISHED SOON] accessed 29.03.2011 </ref> <ref> PR Week [http://www.prweek.com/news/768532/Healthcare-tech-group-enlists-WS/?DCMP=ILC-SEARCH Healthcare Tech Group Enlists WS] 23.11.2007, accessed 16.04.2011 </ref> |
| | | | |
| − | ===AdvaMed===
| + | *[[PB Political Consulting]] is also listed as providing PR services for MTG in the registrar of consultant lobbyists. <ref>[https://registerofconsultantlobbyists.force.com/CLR_Public_Profile?id=00124000006a4yrAAA PB Political Consulting profile 2015], ''Registrar of consultant lobbyists'', accessed 8 February 2016</ref> |
| − | Advanced Medical Technology Association (AdvaMed) is the owner of The Medical Technology Group, logo with slogan (Improving patient access to medical technology). <ref> Markify [http://www.markify.com/trademarks/ctm/the+medical+technology+group+improving+patient+access+to+med/008786303 Detailed trademark information from the CTM database (Countries in the European Union)] accessed 06.04.2011 </ref> AdvaMed lobby politicians in support of legislation that will lead to faster approval of new medical technologies. They want to reduce the regulatory burden, and therefore the cost, of introducing new medical technologies into the market. AdvaMed state that they represents the interests of companies that make medical devices and diagnostic equipment. <ref> Jones, Chloe [http://www.helium.com/items/304089-the-role-of-the-advanced-medical-technology-association-advamed The role of the Advanced Medical Technology Association] 28.04 2007, accessed 06.04.2011 </ref>
| |
| | | | |
| | + | ===Membership benefits=== |
| | + | MTG sends out a weekly report to members with all relevant media coverage, parliamentary activity and government announcements. It includes information about MTG and Weber Shandwick activity “to keep all members in the loop”. <ref> Weber Shandwick. [http://www.scribd.com/doc/42069182/Weber-Shandwick-Presentation-FINAL Medical Technology Group, 2009 End of year review and forward look] accessed 02.04.2011 </ref> Membership also includes: |
| | + | *'Access to professional public affairs advice on matters relating to the Group' |
| | + | *'Training workshops on lobbying effectiveness, media training and other topics' |
| | + | *'Opportunities to meet and network with MPs, patient and professional groups and regulatory bodies such as NICE and NHS PASA. <ref> MTG [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=5 Joining MTG] accessed 11.02.1011 </ref> |
| | | | |
| − | ===Eucomed===
| + | MTG member organizations can be profiled at various events, such as: |
| − | Eucomed represents 4500 designers, manufacturers and suppliers of medical technology used in the diagnosis, prevention, treatment and amelioration of disease and disability. Their members include national trade and pan-European product associations and internationally active manufacturers of all types of medical technology. Their mission is to “improve patient and clinician access to modern, innovative and reliable medical technology”. <ref> MTB Europe [http://www.mtbeurope.info/directory/eucomed.htm Eucomed], accessed 06.04.2011 </ref>
| + | *The Labour, Conservative and Liberal Democrat annual conferences |
| − | | + | *'The Medical Technology Showcase in the Houses of Parliament where your technologies could be exhibited to MPs and Lords' |
| − | ==Benefits of the MTG-membership==
| + | *Articles in MTG’s full-colour ‘Bulletin’ which reaches 1000 senior health decision-makers in parliament and the NHS”. <ref> MTG [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=5 Joining MTG] accessed 11.02.1011 </ref> |
| − | The MTG sends out a weekly report to their members with all media coverage, Parliamentary activity and government announcements relevant to the MTG. In the report, members of the MTG also get information about the MTG and Weber Shandwick activity “to keep all members in the loop” <ref> Weber Shandwick. [http://www.scribd.com/doc/42069182/Weber-Shandwick-Presentation-FINAL Medical Technology Group, 2009 End of year review and forward look] accessed 02.04.2011 </ref>
| |
| − | The MTG membership also includes:
| |
| − | ▪ “Access to professional public affairs advice on matters relating to the Group
| |
| − | ▪ Training workshops on lobbying effectiveness, media training and other topics
| |
| − | ▪ Opportunities to meet and network with MPs, patient and professional groups and regulatory bodies such as NICE and NHS PASA”. <ref> MTG [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=5 Joining MTG] accessed 11.02.1011 </ref>
| |
| − | | |
| − | | |
| − | As a member of the MTG, organizations can be profiled on a variety of events, such as:
| |
| − | ▪ “The Labour, Conservative and Liberal Democrat annual conferences
| |
| − | ▪ The Medical Technology Showcase in the Houses of Parliament where your technologies could be exhibited to MPs and Lords
| |
| − | ▪ Articles in the MTG’s full-colour ‘Bulletin’ which reaches 1,000 senior health decision-makers in parliament and the NHS”. <ref> MTG [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=5 Joining MTG] accessed 11.02.1011 </ref>
| |
| | | | |
| | ==Contacts== | | ==Contacts== |
| − | The MTG lists its PR and lobbying company, [[Weber Shandwick]], as the MTG's secretariat and contact point. Weber Shandwick is the UK subsidiary of Weber Shandwick Worldwide, one of the biggest global PR companies, owned by Interpublic. In 2006, the UK subsidiary had a fee income of £28 million. The company has strong ties to the Labour Party through its CEO Colin Byrne. <ref> Powerbase [http://www.powerbase.info/index.php/Weber_Shandwick#People Weber Shandwick], accessed 29.03.2011 </ref> “Weber Shandwick is to lobby on behalf of a body pushing for greater use of technology in the NHS”. <ref> PR Week [http://www.prweek.com/news/768532/Healthcare-tech-group-enlists-WS/?DCMP=ILC-SEARCH Healthcare Tech Group Enlists WS] 23.11.2007, accessed 16.04.2011 </ref>
| + | MTG secretariat email: mail@mtg.org.uk <ref> MTG [http://www.mtg.org.uk/download/file/pdf/MTG%20Bulletin%20Issue%2021.pdf Medical Technology – Can We Afford to Miss Out?] 21.12.2009, accessed 20.02.2011 </ref> |
| − | | |
| − | | |
| − | “The head office of Weber Shandwick UK and Ireland is located at:
| |
| − | | |
| − | Weber Shandwick
| |
| − | | |
| − | Fox Court
| |
| − | | |
| − | 14 Gray's Inn Road
| |
| − | | |
| − | London
| |
| − | | |
| − | WC1X 8WS
| |
| − | | |
| − | Switchboard: 020 7067 0000
| |
| − | | |
| − | Fax: 0844 875 1463” <ref> Weber Shandwick [http://www.webershandwick.co.uk/company/contact Contact], accessed 29.03.2011] </ref>
| |
| − | | |
| − | "Weber Shandwick provides the Secretariat to the MTG". <ref> MTG and INPUT [http://www.technologyadoptioncentre.nhs.uk/assets/_files/documents/jun_10/nhs__1276784218_Medical_Technology_Group_Infor.pdf AUDIT OF INSULIN PUMP THERAPY PROVISION AT PRIMARY CARE TRUST (PCT) LEVEL TO BE PUBLISHED SOON] accessed 29.03.2011 </ref> If you want to contact the MTG secretariat, use this email: mail@mtg.org.uk <ref> MTG [http://www.mtg.org.uk/download/file/pdf/MTG%20Bulletin%20Issue%2021.pdf Medical Technology – Can We Afford to Miss Out?] 21.12.2009, accessed 20.02.2011 </ref>
| |
| | | | |
| | ==Management Committee== | | ==Management Committee== |
| − | “Members of the committee are:
| + | *Chair – [[Barbara Harpham]], [[Heart Research]] UK |
| − | | + | * Vice-Chair – [[Richard Phillips]], [[Medtronic]] |
| − | ▪ Chair – Barbara Harpham, Heart Research UK
| + | * Treasurer – [[Sandra Lawrence]], [[Stryker]] |
| − | | + | * [[John Davis]], [[INPUT]] |
| − | ▪ Vice-Chair – Richard Phillips, Medtronic
| + | * [[Joe Gatewood]], [[AdvaMed]] |
| − | | + | * [[Nathalie Verin]], [[Boston Scientific]] |
| − | ▪ Treasurer – Sandra Lawrence, Stryker
| + | * [[Kieran Murphy]], [[Johnson & Johnson]] |
| − | | + | * [[Joanna Fearnley]], [[Arrhythmia Alliance]] <ref> MTG [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=3 Management Committee], accessed 11.02.2011 </ref> |
| − | ▪ John Davis, INPUT
| |
| − | | |
| − | ▪ Joe Gatewood, AdvaMed
| |
| − | | |
| − | ▪ Nathalie Verin, Boston Scientific
| |
| − | | |
| − | ▪ Kieran Murphy, Johnson & Johnson
| |
| − | | |
| − | ▪ Joanna Fearnley, Arrhythmia Alliance” <ref> MTG [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=3 Management Committee], accessed 11.02.2011 </ref>
| |
| − | | |
| − | | |
| − | ===Barbara Harpham===
| |
| − | Position of the MTG: Chair
| |
| − | | |
| − | Other job: National Director of Heart Research UK <ref> Heart Research UK [http://www.heartresearch.org.uk/news Lord Mayor of Hull Stops by for Healthy Heart Check] 13.04.2011, accessed 15.04.2011 </ref>
| |
| − | | |
| − | Info about the Hearth Research UK: Heart Research UK was founded in 1967. At this time, cardiac surgery carried serious risks and patients were dying unnecessarily because of the lack of research in heart disease, especially surgical techniques. Today, Heart Research UK is a visionary charity that leads the way funding ground breaking, innovative medical research projects at the cutting edge of science into the prevention, treatment and cure of heart disease. <ref> Heart Research UK [http://www.heartresearch.org.uk/aboutus About us], accessed 29.03.2011 </ref>
| |
| − | | |
| − | Further information about Barbara Harpham: Barbara was, until May 2007, a local Councillor, former Cabinet member and Group Leader on Redcar and Cleveland Council. <ref> Bob King & Associates [http://www.bkanda.co.uk/heart-research.html Foolproof Combination], accessed 04.04.2011 </ref>
| |
| − | | |
| − | | |
| − | Heart Research UK, Contact info:
| |
| − | | |
| − | Tel: 0113 234 7474
| |
| − | | |
| − | Email: info@heartresearch.org.uk
| |
| − | | |
| − | Heart Research UKs homepage: http://www.heartresearch.org.uk/
| |
| − | | |
| − | | |
| − | ===Richard Phillips===
| |
| − | Position of the MTG: Vice-Chair
| |
| − | | |
| − | Other jobs: Gov.&Ind. Affairs Manager of Medtronic, and Director of IMSTA <ref> IMSTA [http://www.imsta.ie/node/44 Richard Devereaux-Phillips], accessed 14.03.2011 </ref>
| |
| − | | |
| − | Info about Medtronic: Medtronic was founded in 1949 in Minneapolis, Minnesota, USA. They claim that they are now the global leader in medical technology, alleviating pain, restoring health and extending life for millions of people around the world <ref> Medtronic [http://www.medtronic.co.uk/about-medtronic/medtronic-uk/index.htm About Medtronic], accessed 04.04.2011 </ref>
| |
| − | | |
| − | Info about IMSTA: IMSTA is the abbreviation for The Irish Medical and Surgical Trade Association, and was established in 1982 to represent the Medical Technology supply industry in Ireland. There goals is: “To improve patient outcomes by promoting better access to optimal medical technologies, to promote the value of the medical device supply industry, to foster an appropriate regulatory environment, and to promote a competitive marketplace. <ref> IMSTA [http://www.imsta.ie/ Welcome to IMSTA], accessed 04.04.2011 </ref>
| |
| − | | |
| − | Further information about Richard Phillips: Richard comes from Blackpool, Lancashire in England, and read a first degree in Sports Science at Brighton Polytechnic before entering the industry as a pharmaceutical representative with pharmaceutical company, Glaxo. “He has been with Medtronic since 1997 and holds postgraduate qualifications in Health Economics for the Universities of Aberdeen and Keele from where he also received an MBA in 2003. As well as IMSTA, Richard is active in the work of the Association of British Healthcare Industries, Eucomed and Advamed. Early in 2008, Richard spent 3 months living and working in Washington DC in Medtronic's Government Affairs Office. He currently serves as the Chair of ABHI's Parliamentary working group and as a member of the Technology Appraisal Advisory Committee of the UK National Institute for Health and Clinical Excellence. Away from work, Richard's major passion is the Cornish Pirates rugby team, for whom he sponsored a player for each of the last three seasons.” Richard and his wife, Luan, live in North Birmingham and West Cornwall, and got their first child in April 2009. <ref> IMSTA [http://www.imsta.ie/node/44 Richard Devereaux-Phillips], accessed 14.03.2011 </ref>
| |
| − | | |
| − | | |
| − | Richard Phillips, Contact info:
| |
| − | | |
| − | Work tel: +44 (1)92 320 5128
| |
| − | | |
| − | E-mail: richard.phillips@medtronic.com
| |
| − | | |
| − | Medtronics homepage: http://www.medtronic.co.uk/
| |
| − | | |
| − | IMSTAs homepage: http://www.imsta.ie/
| |
| − | | |
| − | | |
| − | ===Sandra Lawrence===
| |
| − | Position of the MTG: Treasurer
| |
| − | | |
| − | Other job: Public Affairs and Health Policy Manager at Stryker UK. <ref> Linkedin [http://www.linkedin.com/pub/sandra-lawrence/10/8ba/862 Sandra Lawrence], accessed 06.04.2011 </ref>
| |
| − | | |
| − | Info about Stryker UK: Stryker was founded in 1941. <ref> Stryker UK [http://www.stryker.co.uk/index/st_pag_about-us.htm About us], accessed 06.04.2011 </ref> “Stryker Corporation is a leader in the worldwide orthopaedic market and is one of the world’s largest medical device companies. Stryker delivers results through a wide range of capabilities including joint replacements, trauma, spine and micro implant systems, orthobiologics, powered surgical instruments, surgical navigation systems, endoscopic products as well as patient handling and emergency medical equipment”. <ref> Stryker UK [http://www.stryker.co.uk/ United Kingdom], accessed 06.04.2011 </ref>
| |
| − | | |
| − | Further information about Sandra Lawrence: Sandra lives in Guildford, UK, and used to work as Group Marketing Manager at Stryker. She also represent “Stryker on ABHI Council and other working groups to include:
Public Affairs & Policy Working Group
Health Technology Assessment Group
Orthopaedics Working Group
Spine Working Group
Surgical Instruments Working Group
E-Business & Supply Chain Working Group
PbR Working Group
Procurement Policy Working Group.
Ensure information fed into senior members of organisation on changes in the NHS environment and government policy that may influence Strykers business, and advise on actions of change to meet the business needs”. <ref> Linkedin [http://www.linkedin.com/pub/sandra-lawrence/10/8ba/862 Sandra Lawrence], accessed 06.04.2011 </ref>
| |
| − | | |
| − | | |
| − | Stryker UK, Contact info:
| |
| − | | |
| − | Tel: +44 (0) 1635 262 400
| |
| − | | |
| − | E-mail: Unknown, but its possible to contact Stryker UK through their homepage
| |
| − | | |
| − | Stryker’s homepage: http://www.stryker.co.uk/
| |
| − | | |
| − | ===John Davis===
| |
| − | Position of the MTG: A part of the management committee
| |
| − | | |
| − | Other job: Founder of INPUT
| |
| − | | |
| − | Info about INPUT: John Davis became the founder of INPUT in 1998. INPUT is an independent, not-for-profit organisation run by insulin pump users and their families to raise awareness of diabetes technology, including insulin pump therapy, in the UK. <ref> INPUT [http://www.input.me.uk INPUT], accessed 30.03.2011 </ref> INPUT writes on their homepage that they serve “as a clearinghouse for information on insulin pump therapy and an advocacy group for consistent funding for insulin pump therapy across the UK. NHS Primary Care Trusts must comply with NICE Technology Appraisals, but inadequate governmental supervision of their implementation and little support from the Department of Health to establish best practices have made the NICE guidance on insulin pump therapy very difficult to enforce. INPUT works with Diabetes UK, the JDRF, the Department of Health, members of Parliament, the diabetes care industry, consultant diabetologists, diabetes specialist nurses, general practitioners, and the Insulin Pump Association to bring about full adoption of the NICE guidance on insulin pump therapy”. <ref> INPUT [http://www.input.me.uk/about-input/ About INPUT], accessed 30.03.2011 </ref>
| |
| − | | |
| − | Further information about John Davis: John is a pump user himself since 1997. <ref> INPUT [http://www.input.me.uk/about-input/ About INPUT], accessed 30.03.2011 </ref>. He has type 1 diabetes and is not a medical professional. <ref> Insulin Pumpers [http://www.insulin-pumpers.org.uk/cgmsexperience/ Wearing a continuous glucose sensor], accessed 06.04.2011 </ref>
| |
| − | | |
| − | | |
| − | INPUT and John Davis, Contact info:
| |
| − | | |
| − | INPUTs tel: 0800 228 9977
| |
| − | | |
| − | INPUTs e-mail: input.enquiries@gmail.com
| |
| − | | |
| − | John Davis’s e-mail: john.davis@input.me.uk
| |
| − | | |
| − | INPUTs homepage: http://www.input.me.uk/
| |
| − | | |
| − | | |
| − | ===Joe Gatewood===
| |
| − | Position of the MTG: A part of the management committee
| |
| − | | |
| − | Other job: Vice President, Global Strategy & Analysis
of AdvaMed
| |
| − | | |
| − | Info about AdvaMed: AdvaMed is the abbreviation for Advanced Medical Technology Association. Their headquarters is in
| |
| − | 701 Pennsylvania Ave, N.W. Suite 800
Washington, D.C. 20004-2654 <ref> AdvaMed [http://www.advamed.org/MemberPortal/contactus.htm Contact us], accessed 26.03.2011 </ref> (For more information about AdvaMed, see separate paragraph above).
| |
| − | | |
| − | Further information about Joe Gatewood: Joseph (Joe) has previously worked as Attorney at Broadcasting Board of Governors, Associate, Health Care Practice at Arent Fox, Senior Counsel at HHS Office of Inspector General, Attorney at Department of Health and Human Services, Departmental Appeals Board. He is educated at the American University, Washington College of Law, University of Maryland College Park. <ref> Linkedin [http://www.linkedin.com/profile/view?locale=&id=32635262&authType=name&authToken=eal9 Joseph Gatewood], accessed 06.04.2011 </ref>
| |
| − | | |
| − | | |
| − | AdvaMed, Contact info:
| |
| − | | |
| − | Tel: 202-783-8700
| |
| − | | |
| − | E-mail: info@advamed.org
| |
| − | | |
| − | AdvaMeds homepage: http://www.advamed.org/MemberPortal/
| |
| − | | |
| − | | |
| − | ===Nathalie Verin===
| |
| − | Position of the MTG: A part of the management committee
| |
| − | | |
| − | Other job: Health Economics Manager Boston Scientific UK & Ireland
| |
| − | | |
| − | Info about Boston Scientific: Boston Scientific has offered medical innovations for more than 30 years, they have more than 25 000 employees and is one of the world's largest medical device companies dedicated to less-invasive medicine. They have 17 manufacturing facilities worldwide and more than 13 000 products. In 2009 they invested $1bn in research and development. <ref> Boston Scientific [http://www.bostonscientific.com/AboutUs.bsci/,,/navRelId/1000.1004/seo.serve About us], accessed 08.04.2011 </ref>
| |
| − | | |
| − | Further information about Nathalie Verin: Nathalie has worked in the field of health economics for the medical devices industry over the last six years. She is “a graduate of an MSc in International Health Policy from the London School of Economics, she has worked both as a member of the European Health Economics team as well as the UK Public Affairs/Health Economics team of Boston Scientific. Her experience includes designing health economics models to support technology assessments of medical devices, and improve funding of minimally-invasive technologies. Her role in the UK includes the coordination of company responses to all NICE reviews and expert knowledge of Payment by Results (PbR). She has a particular interest in reimbursement and is currently the Chair of the Industry Group on PbR”. <ref> NICE [http://www.nice.org.uk:80/aboutnice/howwework/devnicetech/technologyappraisalcommittee/members/committee_b_members.jsp Committee B Members] 11.01.2011, accessed 08.04.2011 </ref>
| |
| − | | |
| − | | |
| − | Boston Scientific, Contact info:
| |
| − | | |
| − | Tel: 01442 411600
| |
| − | | |
| − | E-mail: Unknown, but its possible to contact Boston Scientific through their homepage
| |
| − | | |
| − | Boston Scientifics homepage: http://www.bostonscientific-international.com/home.bsci
| |
| − | | |
| − | | |
| − | ===Kieran Murphy===
| |
| − | Position of the MTG: A part of the management committee
| |
| − | | |
| − | Other job: Director of Health Economics & Reimbursement UK at Johnson & Johnson
| |
| − | Info about the other workplace: Johnson & Johnsons main office is in New Brunswick, New Jersey 08933. <ref> Johnson & Johnson [https://secure-www.jnj.com/wps/wcm/jsp/contactUs.jsp Contact us], accessed 01.04.2011 </ref> The three Johnson brothers, Robert Wood Johnson, James Wood Johnson and Edward Mead Johnson, founded it in 1886 in New Brunswick, New Jersey, U.S. <ref> Johnson & Johnson [http://www.jnj.com/connect/about-jnj/company-history/?flash=true Our Timeline], accessed 01.04.2011 </ref> Today, they have more than 250 operating companies in 60 countries employing approximately 114 000 people. They claim that they embrace research and science, bringing innovative ideas, products and services to advance the health and well-being of people <ref> Johnson & Johnson [http://www.jnj.com/connect/about-jnj/ Our company], accessed 01.04.2011 </ref>
| |
| − | | |
| − | Further information about Kieran Murphy: Kieran used to work as Health Economics & Reimbursement Manager UK at Johnson & Johnson. Before that he worked as Health Economics & Market Access Manager at Medtronic, and before that as Research Associate at National Horizon Scanning Centre. He is educated at The University of Birmingham and lives in London, UK. <ref> Linkedin [http://www.linkedin.com/pub/kieran-murphy/4/586/949 Kieran Murphy], accessed 06.04.2011 </ref>
| |
| − | | |
| − | | |
| − | Johnson & Johnson, Contact info:
| |
| − | | |
| − | Tel: (732) 524-0400
| |
| − | | |
| − | E-mail: Unknown, but its possible to contact Johnson & Johnson through their homepage.
| |
| − | | |
| − | Johnson & Johnsons homepage: http://www.jnj.com/connect/
| |
| − | | |
| − | | |
| − | ===Joanna Fearnley===
| |
| − | Position of the MTG: A part of the management committee
| |
| − | | |
| − | Other job: Projects and Campaigns Co-ordinator at Arrhythmia Alliance
| |
| − | | |
| − | Info about the Arrhythmia Alliance: Arrhythmia Alliance is in Oxford, United Kingdom, and it is a nonprofit organization management. <ref> Linkedin [http://www.linkedin.com/pub/joanna-fearnley/22/467/980 Joanna Fearnley], accessed 10.04.2011 </ref> Arrhythmia Alliance writes that they are “a UK registered charity promoting better understanding, diagnosis, treatment and quality of life for individuals with cardiac arrhythmias”. <ref> Arrhythmia Alliance [http://www.heartrhythmcharity.org.uk/ The Heart Rhythm Charity], accessed 10.04.2011 </ref>
| |
| − | | |
| − | Further information about Joanna Fearnley: Joanna joined the Arrhythmia Alliance in September 2008 as the Projects and Campaigns Co-ordinator. She said that most of her “time is spent planning the annual Arrhythmia Awareness Week in June. Each year the plan is to make the event bigger and better”. <ref> Arrhythmia Alliance [http://www.heartrhythmcharity.org.uk/about/our-staff Our staff], accessed 10.04.2011 </ref>
| |
| − | | |
| − | | |
| − | Arrhythmia Alliance, Contact info:
| |
| − | | |
| − | Tel: +44 (0) 1789450787
| |
| − | | |
| − | E-mail: info@heartrhythmcharity.org.uk
| |
| | | | |
| − | Arrhythmia Alliances homepage: http://www.heartrhythmcharity.org.uk/
| + | ==Lobbying activities== |
| − | | |
| − | | |
| − | ==The MTG has achieved== | |
| | | | |
| | ===2008=== | | ===2008=== |
| − | The MTG believes that the “awareness-raising”. By attending the 2008 Party Conferences, The MTG believe that they helped to raise awareness of the under-adoption of medical technology. Under the Party Conferences the MTG offered MPs the chance to check they had healthy hearts. The MTG takes patients’ views to a wider group of MPs and Peers at our annual Parliamentary Showcase. The MTG mean that they appeared regularly in the media, in 2008, to help policy makers and the public learn about the benefits of medical technology. They also think they started to shape the policy agenda. In 2008 the MTG worked with parliamentarians to table an amendment to the Health and Social Care Bill. They means that this encouraged the Care Quality Commission to take into account medical technology’s ability to generate cost savings across Government. The MTG had regular meetings with NICE, and the meetings helped to ensure that insulin pumps were the very first technology to be the subject of a Commissioning Guide. This supported the NHS in providing more patients with diabetes with this “life-changing technology”. The MTG also believes that their submissions to NICE help to convey patients’ views to this key public body, while their briefings to Parliamentarians on current legislation like the Health Bill explain to MPs and Peers the views of their members. <ref> MTG [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=14 MTG successes], accessed 20.02.2011 </ref>
| + | Attended the 2008 Party Conferences, to 'raise awareness of the under-adoption of medical technology'. Offered MPs the chance to check they had healthy hearts. |
| − | | + | :MTG takes patients’ views to a wider group of MPs and Peers at our annual Parliamentary Showcase. MTG appeared regularly in the media, in 2008, to help policymakers and the public learn about the benefits of medical technology. |
| | + | :In 2008 MTG worked with parliamentarians to table an amendment to the [[Health and Social Care Bill]]. It encouraged the [[Care Quality Commission]] to take into account medical technology’s ability to generate cost savings across Government. MTG had "regular meetings with NICE, and the meetings helped to ensure that insulin pumps were the very first technology to be the subject of a Commissioning Guide". |
| | + | :Submissions to NICE helped to convey patients’ views to this key public body, while briefings to Parliamentarians on current legislation like the Health Bill explained to MPs and Peers the views of members. <ref> MTG [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=14 MTG successes], accessed 20.02.2011 </ref> |
| | | | |
| | ===2009=== | | ===2009=== |
| − | The MTG ran a number of campaigns throughout 2009, the activities of the MTG included: Publication of the MTG Action Plan, Research into the wider societal benefits of medical technology, Parliamentary Showcase, and Dedicated campaign activity.
| + | MTG ran a number of campaigns throughout 2009, including: the publication of the MTG Action Plan, research into the wider societal benefits of medical technology, Parliamentary Showcase, and dedicated campaign activity. |
| − | | |
| − | | |
| − | Publication of the MTG Action Plan: The report “Medical Technology – Can we afford to miss out?” highlighted how the UK lags behind many other European countries in its uptake of proven effective technologies. The report gained broad media coverage, including among BBC, HSJ and Pharma Times amongst others. The Action Plan has also been endorsed by front bench MPs from both the Conservative and Liberal Democrats.
| |
| − | | |
| − | | |
| − | Research into the wider societal benefits of medical technology: The MTG commissioned the York Health Economics Consortium to produce a report which would demonstrate the wider societal benefits of medical technologies, the first phase of this was completed in August.
| |
| − | | |
| | | | |
| − | Parliamentary Showcase: The annual Parliamentary Showcase was held on 13 October at Portcullis House. 18 parliamentarians attended over the course of the event including Norman Lamb MP and Sandra Gidley MP from the Shadow Lib Dem health team, high profile labour MPs, the Deputy Speaker of the House of Commons Sir Alan Haselhurst, and a number of Conservative and cross-bench peers with an interest in health.
| + | Publication of MTG Action Plan: The report “Medical Technology – Can we afford to miss out?” which: :highlighted how the UK lags behind many other European countries in its uptake of proven effective technologies. The report gained broad media coverage, including from the BBC, HSJ and Pharma Times amongst others. The Action Plan has also been endorsed by front bench MPs from both the Conservative and Liberal Democrats.
|
| | | | |
| | + | :Research into the wider societal benefits of medical technology: MTG commissioned the York Health Economics Consortium to produce a report which would demonstrate the wider societal benefits of medical technologies, the first phase of this was completed in August. |
| | | | |
| − | Dedicated campaign activity: The MTG ran a number of dedicated campaigns, the first of these was around increasing the uptake of Insulin Pumps. The MTG had liaised with a number of MPs and expect a series of outputs throughout 2010 <ref> ABHI [http://www.abhi.org.uk/key-issues/public-affairs/medical-technology-group.aspx Medical Technology Group], accessed 14.02.2011 </ref>
| + | :The annual Parliamentary Showcase was held on 13 October at Portcullis House. 18 parliamentarians attended including MPs Norman Lamb and [[Sandra Gidley]] from the Shadow Lib Dem health team, high profile labour MPs, the Deputy Speaker of the House of Commons Sir [[Alan Haselhurst]], and a number of Conservative and cross-bench peers with an interest in health.
|
| − |
| |
| | | | |
| − | If you would like to view full summary of the MTG’s achievements in 2009 follow this link: http://www.abhi.org.uk/multimedia/docs/briefings-in-public/Weber%20Shandwick%20presentation%20FINAL.pdf
| + | :MTG ran a number of dedicated campaigns, the first of these was around increasing the uptake of Insulin Pumps. MTG had liaised with a number of MPs and expect a series of outputs throughout 2010 <ref> ABHI [http://www.abhi.org.uk/key-issues/public-affairs/medical-technology-group.aspx Medical Technology Group], accessed 14.02.2011 </ref> |
| | | | |
| | + | See also MTG annual report for 2009: http://www.abhi.org.uk/multimedia/docs/briefings-in-public/Weber%20Shandwick%20presentation%20FINAL.pdf |
| | | | |
| | ===2010=== | | ===2010=== |
| − | Before 2010, the MTG's plan was to “utilise the recently launched Action Plan, focusing on Conservatives and wider stakeholders. They also wanted to “build links with think tanks, seek out speaking opportunities and will be looking at holding fringe events at events such as the RCN Congress”. The MTG also wanted more press coverage in 2010 than the previous year. They also wanted to focus on “patient need”. <ref> ABHI [http://www.abhi.org.uk/key-issues/public-affairs/medical-technology-group.aspx Medical Technology Group], accessed 14.02.2011 </ref>
| + | MTG's plan was to “utilise the recently launched Action Plan, focusing on Conservatives and wider stakeholders", and to “build links with think tanks, seek out speaking opportunities" and hold fringe events at events such as the RCN Congress”. MTG also wanted more press coverage in 2010 than the previous year and to focus on “patient need”. <ref> ABHI [http://www.abhi.org.uk/key-issues/public-affairs/medical-technology-group.aspx Medical Technology Group], accessed 14.02.2011 </ref> |
| | | | |
| | ==Notes== | | ==Notes== |
| | <references/> | | <references/> |
| | [[Category:Healthcare Industry]] | | [[Category:Healthcare Industry]] |
